NOARIE MAGOUN: Open Payments
NPI 1023778024 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 45 payments from 17 companies in 2025. Trend: 2023 $1,371 · 2024 $1,761 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $326 |
| Lilly USA, LLC | 8 | $130 |
| GlaxoSmithKline, LLC. | 4 | $108 |
| PFIZER INC. | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| ABBVIE INC. | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Lundbeck LLC | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
Products named: Wegovy, TRELEGY ELLIPTA, MOUNJARO, Rybelsus, JARDIANCE, PREVNAR 20, GVOKE HYPOPEN, Ozempic.
Industry payments across CA — which companies pay providers there.
